Thirty Madison
Thirty Madison raises $140M Series C at $1B valuation
Quick Facts
Thirty Madison: Series C Funding Round
Thirty Madison has successfully raised $140M in Series C funding, reaching a valuation of $1B.
Company Overview
Multi-specialty telehealth platform
Funding Details
The Series C round was led by Mousse Partners, with participation from Johnson & Johnson Innovation.
Company Information
- Headquarters: New York, NY
- Founded: 2016
- Employees: 400+
- Category: HealthTech
Investment
Thirty Madison plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Mousse Partners: Verified investor in Series C
- Johnson & Johnson Innovation: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
